Concepedia

Publication | Closed Access

Preclinical Evaluation of eFT226, a Novel, Potent and Selective eIF4A Inhibitor with Anti-Tumor Activity in B-Cell Malignancies

DOI

14

Citations

0

References

2017

Year

Peggy A. Thompson, Boreth Eam, Nathan P. Young, Sarah Fish, Joan W. Chen, Maria Barrera, Haleigh Howard, Ana María López‐Parra, Jolene Molter, Jocelyn Staunton,
Blood

No additional data available for this publication yet. Check back later!